Given its wide-ranging roles in tissue homeostasis and injury with multiple protein interactions, pan-inhibition of HIPK2 may yield unwanted side effects, such as pro-oncogenic effects caused by p53 suppression in dampening renal fibrosis in CKD. This evidence concerns the gene HIPK2 and chronic kidney disease.